[Long-term testing of 2-(2,6-dichlorphenylamino)-2-imidazoline hydrochloride with special reference to the effect on blood pressure and carbohydrate metabolism].
D000368:Aged; D000410:Alanine Transaminase / Q000097:blood; D000959:Antihypertensive Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D001219:Aspartate Aminotransferases; D001663:Bilirubin / Q000097:blood; D001794:Blood Pressure / Q000187:drug effects*; D050260:Carbohydrate Metabolism; D003864:Depression, Chemical; D004361:Drug Tolerance; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000201:enzymology; D007093:Imidazoles / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D007677:Kidney Function Tests; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D013268:Stimulation, Chemical; D013997:Time Factors
D000959:Antihypertensive Agents; D007093:Imidazoles; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D001663:Bilirubin
Bericht über eine Langzeitprüfung mit 2-(2,6-Dichlorphenylamino)-2-imidazolon-hydrochloridunter besonderer Berücksichtigung der Wirkung auf den Blutdruck und des Kohlenhydratstoffwechsels.